APO Research
Talk to an analyst

APO RESEARCH · REPORT

Albendazole Anthelmintic Drug

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Albendazole Anthelmintic Drug Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

2 January 2026192 pages

Choose your research edition.

Industry ResearchAlbendazole Anthelmintic Drug Industry Research Report 2026128 pages · $2,950 USDIndustry Growth & TrendsGlobal Albendazole Anthelmintic Drug Industry Growth and Trends Forecast to 2032100 pages · $3,450 USDMarket StructureGlobal Albendazole Anthelmintic Drug Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032192 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Albendazole Anthelmintic Drug Market Outlook and Growth Opportunities 2026190 pages · $4,250 USDMarket Analysis & ForecastGlobal Albendazole Anthelmintic Drug Market Analysis and Forecast 2026-2032194 pages · $4,950 USD

Market perspective

The global Albendazole Anthelmintic Drug market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Albendazole Anthelmintic Drug is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Albendazole Anthelmintic Drug is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Albendazole Anthelmintic Drug is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Albendazole Anthelmintic Drug is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Albendazole Anthelmintic Drug include Jiangsu Qihui, Huazhong Pharmaceutical, GlaxoSmithKline, Zhongjia Pharmaceutical, Supharma Chem, Sequent Scientific, Salius Pharma, Lasa Supergenerics Limited and K.A. Malle Pharmaceuticals, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Albendazole Anthelmintic Drug market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Albendazole Anthelmintic Drug and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Albendazole Anthelmintic Drug sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Albendazole Anthelmintic Drug market size, projected growth trends, production technologies, key applications, and end-use industries.

Albendazole Anthelmintic Drug Segment by Company

Jiangsu Qihui

Huazhong Pharmaceutical

GlaxoSmithKline

Zhongjia Pharmaceutical

Supharma Chem

Sequent Scientific

Salius Pharma

Lasa Supergenerics Limited

K.A. Malle Pharmaceuticals

Fredun Pharmaceuticals Ltd

Albendazole Anthelmintic Drug Segment by Type

Tablet

Capsule

Other

Albendazole Anthelmintic Drug Segment by Application

Human

Veterinary

Albendazole Anthelmintic Drug Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Albendazole Anthelmintic Drug market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Albendazole Anthelmintic Drug and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Albendazole Anthelmintic Drug.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Albendazole Anthelmintic Drug market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Albendazole Anthelmintic Drug manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Albendazole Anthelmintic Drug in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Albendazole Anthelmintic Drug in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Albendazole Anthelmintic Drug Industry Trends Table 2. Albendazole Anthelmintic Drug Industry Drivers Table 3. Albendazole Anthelmintic Drug Industry Opportunities and Challenges Table 4. Albendazole Anthelmintic Drug Industry Restraints Table 5. Global Albendazole Anthelmintic Drug Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Albendazole Anthelmintic Drug Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Albendazole Anthelmintic Drug Sales by Manufacturers (K Units) & (2021-2026) Table 8. Global Albendazole Anthelmintic Drug Sales Market Share by Manufacturers Table 9. Global Albendazole Anthelmintic Drug Average Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 10. Global Albendazole Anthelmintic Drug Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Albendazole Anthelmintic Drug Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Albendazole Anthelmintic Drug Manufacturers, Product Type & Application Table 13. Global Albendazole Anthelmintic Drug Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Albendazole Anthelmintic Drug by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of Tablet Table 17. Major Manufacturers of Capsule Table 18. Major Manufacturers of Other Table 19. Global Albendazole Anthelmintic Drug Sales by Type 2021 VS 2025 VS 2032 (K Units) Table 20. Global Albendazole Anthelmintic Drug Sales by Type (2021-2026) & (K Units) Table 21. Global Albendazole Anthelmintic Drug Sales by Type (2027-2032) & (K Units) Table 22. Global Albendazole Anthelmintic Drug Sales Market Share by Type (2021-2026) Table 23. Global Albendazole Anthelmintic Drug Sales Market Share by Type (2027-2032) Table 24. Global Albendazole Anthelmintic Drug Revenue by Type 2021 VS 2025 VS 2032 (K Units) Table 25. Global Albendazole Anthelmintic Drug Revenue by Type (2021-2026) & (K Units) Table 26. Global Albendazole Anthelmintic Drug Revenue by Type (2027-2032) & (K Units) Table 27. Global Albendazole Anthelmintic Drug Revenue Market Share by Type (2021-2026) Table 28. Global Albendazole Anthelmintic Drug Revenue Market Share by Type (2027-2032) Table 29. Major Manufacturers of Human Table 30. Major Manufacturers of Veterinary Table 31. Global Albendazole Anthelmintic Drug Sales by Application 2021 VS 2025 VS 2032 (K Units) Table 32. Global Albendazole Anthelmintic Drug Sales by Application (2021-2026) & (K Units) Table 33. Global Albendazole Anthelmintic Drug Sales by Application (2027-2032) & (K Units) Table 34. Global Albendazole Anthelmintic Drug Sales Market Share by Application (2021-2026) Table 35. Global Albendazole Anthelmintic Drug Sales Market Share by Application (2027-2032) Table 36. Global Albendazole Anthelmintic Drug Revenue by Application 2021 VS 2025 VS 2032 (K Units) Table 37. Global Albendazole Anthelmintic Drug Revenue by Application (2021-2026) & (K Units) Table 38. Global Albendazole Anthelmintic Drug Revenue by Application (2027-2032) & (K Units) Table 39. Global Albendazole Anthelmintic Drug Revenue Market Share by Application (2021-2026) Table 40. Global Albendazole Anthelmintic Drug Revenue Market Share by Application (2027-2032) Table 41. Global Albendazole Anthelmintic Drug Sales by Region: 2021 VS 2025 VS 2032 (K Units) Table 42. Global Albendazole Anthelmintic Drug Sales by Region (2021-2026) & (K Units) Table 43. Global Albendazole Anthelmintic Drug Sales Market Share by Region (2021-2026) Table 44. Global Albendazole Anthelmintic Drug Sales Forecasted by Region (2027-2032) & (K Units) Table 45. Global Albendazole Anthelmintic Drug Sales Forecasted Market Share by Region (2027-2032) Table 46. North America Albendazole Anthelmintic Drug Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 47. North America Albendazole Anthelmintic Drug Sales by Country (2021-2026) & (K Units) Table 48. North America Albendazole Anthelmintic Drug Sales by Country (2027-2032) & (K Units) Table 49. Europe Albendazole Anthelmintic Drug Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 50. Europe Albendazole Anthelmintic Drug Sales by Country (2021-2026) & (K Units) Table 51. Europe Albendazole Anthelmintic Drug Sales by Country (2027-2032) & (K Units) Table 52. Asia Pacific Albendazole Anthelmintic Drug Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 53. Asia Pacific Albendazole Anthelmintic Drug Sales by Country (2021-2026) & (K Units) Table 54. Asia Pacific Albendazole Anthelmintic Drug Sales by Country (2027-2032) & (K Units) Table 55. South America, Middle East and Africa Albendazole Anthelmintic Drug Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 56. South America, Middle East and Africa Albendazole Anthelmintic Drug Sales by Country (2021-2026) & (K Units) Table 57. South America, Middle East and Africa Albendazole Anthelmintic Drug Sales by Country (2027-2032) & (K Units) Table 58. Global Albendazole Anthelmintic Drug Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 59. Global Albendazole Anthelmintic Drug Revenue by Region (2021-2026) & (US$ Million) Table 60. Global Albendazole Anthelmintic Drug Revenue by Region (2027-2032) & (US$ Million) Table 61. Global Albendazole Anthelmintic Drug Revenue Market Share by Region (2021-2026) Table 62. Global Albendazole Anthelmintic Drug Revenue Market Share by Region (2027-2032) Table 63. Jiangsu Qihui Company Information Table 64. Jiangsu Qihui Business Overview Table 65. Jiangsu Qihui Albendazole Anthelmintic Drug Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 66. Jiangsu Qihui Albendazole Anthelmintic Drug Product Portfolio Table 67. Jiangsu Qihui Recent Development Table 68. Huazhong Pharmaceutical Company Information Table 69. Huazhong Pharmaceutical Business Overview Table 70. Huazhong Pharmaceutical Albendazole Anthelmintic Drug Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 71. Huazhong Pharmaceutical Albendazole Anthelmintic Drug Product Portfolio Table 72. Huazhong Pharmaceutical Recent Development Table 73. GlaxoSmithKline Company Information Table 74. GlaxoSmithKline Business Overview Table 75. GlaxoSmithKline Albendazole Anthelmintic Drug Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 76. GlaxoSmithKline Albendazole Anthelmintic Drug Product Portfolio Table 77. GlaxoSmithKline Recent Development Table 78. Zhongjia Pharmaceutical Company Information Table 79. Zhongjia Pharmaceutical Business Overview Table 80. Zhongjia Pharmaceutical Albendazole Anthelmintic Drug Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 81. Zhongjia Pharmaceutical Albendazole Anthelmintic Drug Product Portfolio Table 82. Zhongjia Pharmaceutical Recent Development Table 83. Supharma Chem Company Information Table 84. Supharma Chem Business Overview Table 85. Supharma Chem Albendazole Anthelmintic Drug Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 86. Supharma Chem Albendazole Anthelmintic Drug Product Portfolio Table 87. Supharma Chem Recent Development Table 88. Sequent Scientific Company Information Table 89. Sequent Scientific Business Overview Table 90. Sequent Scientific Albendazole Anthelmintic Drug Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 91. Sequent Scientific Albendazole Anthelmintic Drug Product Portfolio Table 92. Sequent Scientific Recent Development Table 93. Salius Pharma Company Information Table 94. Salius Pharma Business Overview Table 95. Salius Pharma Albendazole Anthelmintic Drug Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 96. Salius Pharma Albendazole Anthelmintic Drug Product Portfolio Table 97. Salius Pharma Recent Development Table 98. Lasa Supergenerics Limited Company Information Table 99. Lasa Supergenerics Limited Business Overview Table 100. Lasa Supergenerics Limited Albendazole Anthelmintic Drug Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 101. Lasa Supergenerics Limited Albendazole Anthelmintic Drug Product Portfolio Table 102. Lasa Supergenerics Limited Recent Development Table 103. K.A. Malle Pharmaceuticals Company Information Table 104. K.A. Malle Pharmaceuticals Business Overview Table 105. K.A. Malle Pharmaceuticals Albendazole Anthelmintic Drug Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 106. K.A. Malle Pharmaceuticals Albendazole Anthelmintic Drug Product Portfolio Table 107. K.A. Malle Pharmaceuticals Recent Development Table 108. Fredun Pharmaceuticals Ltd Company Information Table 109. Fredun Pharmaceuticals Ltd Business Overview Table 110. Fredun Pharmaceuticals Ltd Albendazole Anthelmintic Drug Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 111. Fredun Pharmaceuticals Ltd Albendazole Anthelmintic Drug Product Portfolio Table 112. Fredun Pharmaceuticals Ltd Recent Development Table 113. Key Raw Materials Table 114. Raw Materials Key Suppliers Table 115. Albendazole Anthelmintic Drug Distributors List Table 116. Albendazole Anthelmintic Drug Customers List Table 117. Research Programs/Design for This Report Table 118. Authors List of This Report Table 119. Secondary Sources Table 120. Primary Sources List of Figures Figure 1. Albendazole Anthelmintic Drug Product Image Figure 2. Global Albendazole Anthelmintic Drug Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Albendazole Anthelmintic Drug Market Size (2021-2032) & (US$ Million) Figure 4. Global Albendazole Anthelmintic Drug Sales (2021-2032) & (K Units) Figure 5. Global Albendazole Anthelmintic Drug Average Price (US$/Unit) & (2021-2032) Figure 6. Global Top 5 and 10 Albendazole Anthelmintic Drug Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. Tablet Image Figure 9. Capsule Image Figure 10. Other Image Figure 11. Global Albendazole Anthelmintic Drug Sales by Type (2021 VS 2025 VS 2032) & (K Units) Figure 12. Global Albendazole Anthelmintic Drug Sales Market Share 2021 VS 2025 VS 2032 Figure 13. Global Albendazole Anthelmintic Drug Sales Market Share by Type (2021-2032) Figure 14. Global Albendazole Anthelmintic Drug Revenue by Type (2021 VS 2025 VS 2032) & (K Units) Figure 15. Global Albendazole Anthelmintic Drug Revenue Market Share 2021 VS 2025 VS 2032 Figure 16. Global Albendazole Anthelmintic Drug Revenue Market Share by Type (2021-2032) Figure 17. Human Image Figure 18. Veterinary Image Figure 19. Global Albendazole Anthelmintic Drug Sales by Application (2021 VS 2025 VS 2032) & (K Units) Figure 20. Global Albendazole Anthelmintic Drug Sales Market Share 2021 VS 2025 VS 2032 Figure 21. Global Albendazole Anthelmintic Drug Sales Market Share by Application (2021-2032) Figure 22. Global Albendazole Anthelmintic Drug Revenue by Application (2021 VS 2025 VS 2032) & (K Units) Figure 23. Global Albendazole Anthelmintic Drug Revenue Market Share 2021 VS 2025 VS 2032 Figure 24. Global Albendazole Anthelmintic Drug Revenue Market Share by Application (2021-2032) Figure 25. North America Albendazole Anthelmintic Drug Sales and Growth Rate (2021-2032) & (K Units) Figure 26. North America Albendazole Anthelmintic Drug Sales Market Share by Country (2021-2032) Figure 27. U.S. Albendazole Anthelmintic Drug Sales and Growth Rate (2021-2032) & (K Units) Figure 28. Canada Albendazole Anthelmintic Drug Sales and Growth Rate (2021-2032) & (K Units) Figure 29. Mexico Albendazole Anthelmintic Drug Sales and Growth Rate (2021-2032) & (K Units) Figure 30. Europe Albendazole Anthelmintic Drug Sales and Growth Rate (2021-2032) & (K Units) Figure 31. Europe Albendazole Anthelmintic Drug Sales Market Share by Country (2021-2032) Figure 32. Germany Albendazole Anthelmintic Drug Sales and Growth Rate (2021-2032) & (K Units) Figure 33. France Albendazole Anthelmintic Drug Sales and Growth Rate (2021-2032) & (K Units) Figure 34. U.K. Albendazole Anthelmintic Drug Sales and Growth Rate (2021-2032) & (K Units) Figure 35. Italy Albendazole Anthelmintic Drug Sales and Growth Rate (2021-2032) & (K Units) Figure 36. Netherlands Albendazole Anthelmintic Drug Sales and Growth Rate (2021-2032) & (K Units) Figure 37. Asia Pacific Albendazole Anthelmintic Drug Sales and Growth Rate (2021-2032) & (K Units) Figure 38. Asia Pacific Albendazole Anthelmintic Drug Sales Market Share by Country (2021-2032) Figure 39. China Albendazole Anthelmintic Drug Sales and Growth Rate (2021-2032) & (K Units) Figure 40. Japan Albendazole Anthelmintic Drug Sales and Growth Rate (2021-2032) & (K Units) Figure 41. South Korea Albendazole Anthelmintic Drug Sales and Growth Rate (2021-2032) & (K Units) Figure 42. Southeast Asia Albendazole Anthelmintic Drug Sales and Growth Rate (2021-2032) & (K Units) Figure 43. India Albendazole Anthelmintic Drug Sales and Growth Rate (2021-2032) & (K Units) Figure 44. Australia Albendazole Anthelmintic Drug Sales and Growth Rate (2021-2032) & (K Units) Figure 45. South America, Middle East and Africa Albendazole Anthelmintic Drug Sales and Growth Rate (2021-2032) & (K Units) Figure 46. South America, Middle East and Africa Albendazole Anthelmintic Drug Sales Market Share by Country (2021-2032) Figure 47. Brazil Albendazole Anthelmintic Drug Sales and Growth Rate (2021-2032) & (K Units) Figure 48. South Africa Albendazole Anthelmintic Drug Sales and Growth Rate (2021-2032) & (K Units) Figure 49. Saudi Arabia Albendazole Anthelmintic Drug Sales and Growth Rate (2021-2032) & (K Units) Figure 50. Turkey Albendazole Anthelmintic Drug Sales and Growth Rate (2021-2032) & (K Units) Figure 51. Argentina Albendazole Anthelmintic Drug Sales and Growth Rate (2021-2032) & (K Units) Figure 52. UAE Albendazole Anthelmintic Drug Sales and Growth Rate (2021-2032) & (K Units) Figure 53. Egypt Albendazole Anthelmintic Drug Sales and Growth Rate (2021-2032) & (K Units) Figure 54. Chile Albendazole Anthelmintic Drug Sales and Growth Rate (2021-2032) & (K Units) Figure 55. Global Albendazole Anthelmintic Drug Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Global Albendazole Anthelmintic Drug Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 57. North America Albendazole Anthelmintic Drug Revenue (2021-2032) & (US$ Million) Figure 58. North America Albendazole Anthelmintic Drug Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 59. Europe Albendazole Anthelmintic Drug Revenue (2021-2032) & (US$ Million) Figure 60. Europe Albendazole Anthelmintic Drug Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 61. Asia-Pacific Albendazole Anthelmintic Drug Revenue (2021-2032) & (US$ Million) Figure 62. Asia-Pacific Albendazole Anthelmintic Drug Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 63. South America, Middle East and Africa Albendazole Anthelmintic Drug Revenue (2021-2032) & (US$ Million) Figure 64. South America, Middle East and Africa Albendazole Anthelmintic Drug Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 65. Albendazole Anthelmintic Drug Value Chain Figure 66. Manufacturing Cost Structure Figure 67. Albendazole Anthelmintic Drug Production Mode & Process Figure 68. Direct Comparison with Distribution Share Figure 69. Distributors Profiles Figure 70. Years Considered Figure 71. Research Process Figure 72. Key Executives Interviewed

Scope & coverage.

Types
  • Tablet
  • Capsule
  • Other
Applications
  • Human
  • Veterinary
Companies covered
  • Jiangsu Qihui
  • Huazhong Pharmaceutical
  • GlaxoSmithKline
  • Zhongjia Pharmaceutical
  • Supharma Chem
  • Sequent Scientific
  • Salius Pharma
  • Lasa Supergenerics Limited
  • K.A. Malle Pharmaceuticals
  • Fredun Pharmaceuticals Ltd

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Albendazole Anthelmintic Drug Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Albendazole Anthelmintic Drug Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Albendazole Anthelmintic Drug Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Albendazole Anthelmintic Drug Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Albendazole Anthelmintic Drug Market Dynamics
  1. 2.1 Albendazole Anthelmintic Drug Industry Trends
  2. 2.2 Albendazole Anthelmintic Drug Industry Drivers
  3. 2.3 Albendazole Anthelmintic Drug Industry Opportunities and Challenges
  4. 2.4 Albendazole Anthelmintic Drug Industry Restraints
3 Albendazole Anthelmintic Drug Market by Manufacturers
  1. 3.1 Global Albendazole Anthelmintic Drug Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Albendazole Anthelmintic Drug Sales by Manufacturers (2021-2026)
  3. 3.3 Global Albendazole Anthelmintic Drug Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Albendazole Anthelmintic Drug Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Albendazole Anthelmintic Drug Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Albendazole Anthelmintic Drug Manufacturers, Product Type & Application
  7. 3.7 Global Albendazole Anthelmintic Drug Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Albendazole Anthelmintic Drug Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Albendazole Anthelmintic Drug Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Albendazole Anthelmintic Drug Tier 1, Tier 2, and Tier 3
4 Albendazole Anthelmintic Drug Market by Type
  1. 4.1 Albendazole Anthelmintic Drug Type Introduction
  2. 4.1.1 Tablet
  3. 4.1.2 Capsule
  4. 4.1.3 Other
  5. 4.2 Global Albendazole Anthelmintic Drug Sales by Type
  6. 4.2.1 Global Albendazole Anthelmintic Drug Sales by Type (2021 VS 2025 VS 2032)
  7. 4.2.2 Global Albendazole Anthelmintic Drug Sales by Type (2021-2032)
  8. 4.2.3 Global Albendazole Anthelmintic Drug Sales Market Share by Type (2021-2032)
  9. 4.3 Global Albendazole Anthelmintic Drug Revenue by Type
  10. 4.3.1 Global Albendazole Anthelmintic Drug Revenue by Type (2021 VS 2025 VS 2032)
  11. 4.3.2 Global Albendazole Anthelmintic Drug Revenue by Type (2021-2032)
  12. 4.3.3 Global Albendazole Anthelmintic Drug Revenue Market Share by Type (2021-2032)
5 Albendazole Anthelmintic Drug Market by Application
  1. 5.1 Albendazole Anthelmintic Drug Application Introduction
  2. 5.1.1 Human
  3. 5.1.2 Veterinary
  4. 5.2 Global Albendazole Anthelmintic Drug Sales by Application
  5. 5.2.1 Global Albendazole Anthelmintic Drug Sales by Application (2021 VS 2025 VS 2032)
  6. 5.2.2 Global Albendazole Anthelmintic Drug Sales by Application (2021-2032)
  7. 5.2.3 Global Albendazole Anthelmintic Drug Sales Market Share by Application (2021-2032)
  8. 5.3 Global Albendazole Anthelmintic Drug Revenue by Application
  9. 5.3.1 Global Albendazole Anthelmintic Drug Revenue by Application (2021 VS 2025 VS 2032)
  10. 5.3.2 Global Albendazole Anthelmintic Drug Revenue by Application (2021-2032)
  11. 5.3.3 Global Albendazole Anthelmintic Drug Revenue Market Share by Application (2021-2032)
6 Global Albendazole Anthelmintic Drug Sales by Region
  1. 6.1 Global Albendazole Anthelmintic Drug Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Albendazole Anthelmintic Drug Sales by Region (2021-2032)
  3. 6.2.1 Global Albendazole Anthelmintic Drug Sales by Region (2021-2026)
  4. 6.2.2 Global Albendazole Anthelmintic Drug Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Albendazole Anthelmintic Drug Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Albendazole Anthelmintic Drug Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Albendazole Anthelmintic Drug Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Albendazole Anthelmintic Drug Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Albendazole Anthelmintic Drug Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Albendazole Anthelmintic Drug Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Albendazole Anthelmintic Drug Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Albendazole Anthelmintic Drug Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Albendazole Anthelmintic Drug Revenue by Region
  1. 7.1 Global Albendazole Anthelmintic Drug Revenue by Region
  2. 7.1.1 Global Albendazole Anthelmintic Drug Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Albendazole Anthelmintic Drug Revenue by Region (2021-2026)
  4. 7.1.3 Global Albendazole Anthelmintic Drug Revenue by Region (2027-2032)
  5. 7.1.4 Global Albendazole Anthelmintic Drug Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Albendazole Anthelmintic Drug Revenue (2021-2032)
  8. 7.2.2 North America Albendazole Anthelmintic Drug Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Albendazole Anthelmintic Drug Revenue (2021-2032)
  11. 7.3.2 Europe Albendazole Anthelmintic Drug Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Albendazole Anthelmintic Drug Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Albendazole Anthelmintic Drug Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Albendazole Anthelmintic Drug Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Albendazole Anthelmintic Drug Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 Jiangsu Qihui
  2. 8.1.1 Jiangsu Qihui Company Information
  3. 8.1.2 Jiangsu Qihui Business Overview
  4. 8.1.3 Jiangsu Qihui Albendazole Anthelmintic Drug Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Jiangsu Qihui Albendazole Anthelmintic Drug Product Portfolio
  6. 8.1.5 Jiangsu Qihui Recent Developments
  7. 8.2 Huazhong Pharmaceutical
  8. 8.2.1 Huazhong Pharmaceutical Company Information
  9. 8.2.2 Huazhong Pharmaceutical Business Overview
  10. 8.2.3 Huazhong Pharmaceutical Albendazole Anthelmintic Drug Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Huazhong Pharmaceutical Albendazole Anthelmintic Drug Product Portfolio
  12. 8.2.5 Huazhong Pharmaceutical Recent Developments
  13. 8.3 GlaxoSmithKline
  14. 8.3.1 GlaxoSmithKline Company Information
  15. 8.3.2 GlaxoSmithKline Business Overview
  16. 8.3.3 GlaxoSmithKline Albendazole Anthelmintic Drug Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 GlaxoSmithKline Albendazole Anthelmintic Drug Product Portfolio
  18. 8.3.5 GlaxoSmithKline Recent Developments
  19. 8.4 Zhongjia Pharmaceutical
  20. 8.4.1 Zhongjia Pharmaceutical Company Information
  21. 8.4.2 Zhongjia Pharmaceutical Business Overview
  22. 8.4.3 Zhongjia Pharmaceutical Albendazole Anthelmintic Drug Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Zhongjia Pharmaceutical Albendazole Anthelmintic Drug Product Portfolio
  24. 8.4.5 Zhongjia Pharmaceutical Recent Developments
  25. 8.5 Supharma Chem
  26. 8.5.1 Supharma Chem Company Information
  27. 8.5.2 Supharma Chem Business Overview
  28. 8.5.3 Supharma Chem Albendazole Anthelmintic Drug Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Supharma Chem Albendazole Anthelmintic Drug Product Portfolio
  30. 8.5.5 Supharma Chem Recent Developments
  31. 8.6 Sequent Scientific
  32. 8.6.1 Sequent Scientific Company Information
  33. 8.6.2 Sequent Scientific Business Overview
  34. 8.6.3 Sequent Scientific Albendazole Anthelmintic Drug Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Sequent Scientific Albendazole Anthelmintic Drug Product Portfolio
  36. 8.6.5 Sequent Scientific Recent Developments
  37. 8.7 Salius Pharma
  38. 8.7.1 Salius Pharma Company Information
  39. 8.7.2 Salius Pharma Business Overview
  40. 8.7.3 Salius Pharma Albendazole Anthelmintic Drug Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Salius Pharma Albendazole Anthelmintic Drug Product Portfolio
  42. 8.7.5 Salius Pharma Recent Developments
  43. 8.8 Lasa Supergenerics Limited
  44. 8.8.1 Lasa Supergenerics Limited Company Information
  45. 8.8.2 Lasa Supergenerics Limited Business Overview
  46. 8.8.3 Lasa Supergenerics Limited Albendazole Anthelmintic Drug Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Lasa Supergenerics Limited Albendazole Anthelmintic Drug Product Portfolio
  48. 8.8.5 Lasa Supergenerics Limited Recent Developments
  49. 8.9 K.A. Malle Pharmaceuticals
  50. 8.9.1 K.A. Malle Pharmaceuticals Company Information
  51. 8.9.2 K.A. Malle Pharmaceuticals Business Overview
  52. 8.9.3 K.A. Malle Pharmaceuticals Albendazole Anthelmintic Drug Sales, Price, Revenue and Gross Margin (2021-2026)
  53. 8.9.4 K.A. Malle Pharmaceuticals Albendazole Anthelmintic Drug Product Portfolio
  54. 8.9.5 K.A. Malle Pharmaceuticals Recent Developments
  55. 8.10 Fredun Pharmaceuticals Ltd
  56. 8.10.1 Fredun Pharmaceuticals Ltd Company Information
  57. 8.10.2 Fredun Pharmaceuticals Ltd Business Overview
  58. 8.10.3 Fredun Pharmaceuticals Ltd Albendazole Anthelmintic Drug Sales, Price, Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Fredun Pharmaceuticals Ltd Albendazole Anthelmintic Drug Product Portfolio
  60. 8.10.5 Fredun Pharmaceuticals Ltd Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Albendazole Anthelmintic Drug Value Chain Analysis
  2. 9.1.1 Albendazole Anthelmintic Drug Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Albendazole Anthelmintic Drug Production Mode & Process
  6. 9.2 Albendazole Anthelmintic Drug Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Albendazole Anthelmintic Drug Distributors
  9. 9.2.3 Albendazole Anthelmintic Drug Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst